Meet the 2021 Laureates: James R. Gavin, III, MD, PhD 

  • By Camille E. Powe, MD, assistant professor, Harvard Medical School, Diabetes Unit, Massachusetts General Hospital, Boston, Ma.
  • Feb 2021
JRGavin photo

Outstanding Mentor Award

 James R. Gavin, III, MD, PhD 

James Raphael Gavin III, MD, PhD, is a clinical professor of medicine at Emory University and Indiana University, the CEO & Chief Medical Officer of Healing Our Village, Inc., and the national program director emeritus for the Robert Wood Johnson Foundation (RWJF) Harold Amos Medical Faculty Development Program (AMFDP).

Dr. Gavin was the first African American president of the American Diabetes Association (1993-1994) and is a past president of Morehouse School of Medicine, one of three historically black medical schools in the U.S. (2002-2005). He has made unparalleled contributions to endocrinology through his pioneering research in diabetes, leadership, advocacy, and, most notably, his dedication to advancing the careers of students, trainees, and physician-scientists (both early career and established) through mentorship. Dr. Gavin’s wisdom, warmth, and critical input at key moments in his mentees’ careers have had a lasting impact.

Dr. Gavin has served as direct mentor to more than 50 early stage physician-scientists and has touched the careers of countless others through his leadership of both the Howard Hughes Medical Institute-National Institutes of Health (NIH) Medical Research Scholars Program and the RWJF AMFDP. During his more than 35-year involvement with the RWJF AMFDP, both as a National Advisory Committee member (1983-present) and national program director (1993- 2013), he has contributed to the career development of over 300 minority physician-scientists.

Among these individuals are three current NIH institute directors (including the NIDDK), our Endocrine Society past president, and over 90 full professors at leading medical schools, a considerable proportion of whom are division chiefs, department chairs, and deans.

Throughout his career, his tireless dedication to increasing the number of medical school faculty from underrepresented minority groups has made an indelible mark on the diversity of leaders in endocrinology at the highest level.

 

 

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    By Richard Ross, Emeritus Professor of Endocrinology, University of Sheffield, UK, and Helen Storr, Professor of Pediatric Endocrinology, Queen Mary University London

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in